Correlation Between Eagle Pharmaceuticals and Mc Endvrs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eagle Pharmaceuticals and Mc Endvrs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eagle Pharmaceuticals and Mc Endvrs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eagle Pharmaceuticals and Mc Endvrs, you can compare the effects of market volatilities on Eagle Pharmaceuticals and Mc Endvrs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eagle Pharmaceuticals with a short position of Mc Endvrs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eagle Pharmaceuticals and Mc Endvrs.

Diversification Opportunities for Eagle Pharmaceuticals and Mc Endvrs

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Eagle and MSMY is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Eagle Pharmaceuticals and Mc Endvrs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mc Endvrs and Eagle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eagle Pharmaceuticals are associated (or correlated) with Mc Endvrs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mc Endvrs has no effect on the direction of Eagle Pharmaceuticals i.e., Eagle Pharmaceuticals and Mc Endvrs go up and down completely randomly.

Pair Corralation between Eagle Pharmaceuticals and Mc Endvrs

Given the investment horizon of 90 days Eagle Pharmaceuticals is expected to under-perform the Mc Endvrs. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eagle Pharmaceuticals is 2.19 times less risky than Mc Endvrs. The pink sheet trades about -0.09 of its potential returns per unit of risk. The Mc Endvrs is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  0.12  in Mc Endvrs on September 12, 2024 and sell it today you would lose (0.05) from holding Mc Endvrs or give up 41.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy62.9%
ValuesDaily Returns

Eagle Pharmaceuticals  vs.  Mc Endvrs

 Performance 
       Timeline  
Eagle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eagle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Mc Endvrs 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mc Endvrs are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, Mc Endvrs showed solid returns over the last few months and may actually be approaching a breakup point.

Eagle Pharmaceuticals and Mc Endvrs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eagle Pharmaceuticals and Mc Endvrs

The main advantage of trading using opposite Eagle Pharmaceuticals and Mc Endvrs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eagle Pharmaceuticals position performs unexpectedly, Mc Endvrs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mc Endvrs will offset losses from the drop in Mc Endvrs' long position.
The idea behind Eagle Pharmaceuticals and Mc Endvrs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets